Cargando…

Aggregated Tau-PHF6 (VQIVYK) Potentiates NLRP3 Inflammasome Expression and Autophagy in Human Microglial Cells

Intra-neuronal misfolding of monomeric tau protein to toxic β-sheet rich neurofibrillary tangles is a hallmark of Alzheimer’s disease (AD). Tau pathology correlates not only with progressive dementia but also with microglia-mediated inflammation in AD. Amyloid-beta (Aβ), another pathogenic peptide i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panda, Chinmaya, Voelz, Clara, Habib, Pardes, Mevissen, Christian, Pufe, Thomas, Beyer, Cordian, Gupta, Sharad, Slowik, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304967/ https://www.ncbi.nlm.nih.gov/pubmed/34209408 http://dx.doi.org/10.3390/cells10071652

Ejemplares similares

Transient Focal Cerebral Ischemia Leads to miRNA Alterations in Different Brain Regions, Blood Serum, Liver, and Spleen
por: Voelz, Clara, et al.
Publicado: (2021)

Gonadal Hormones E2 and P Mitigate Cerebral Ischemia-Induced Upregulation of the AIM2 and NLRC4 Inflammasomes in Rats
por: Habib, Pardes, et al.
Publicado: (2020)

α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β(1–42)-stimulated murine astrocytes
por: Ebrahimi, Taraneh, et al.
Publicado: (2018)

Erythropoietin Enhances Post-ischemic Migration and Phagocytosis and Alleviates the Activation of Inflammasomes in Human Microglial Cells
por: Arik, Eren, et al.
Publicado: (2022)

Residue-based propensity of aggregation in the Tau amyloidogenic hexapeptides AcPHF6* and AcPHF6
por: Dangi, Abha, et al.
Publicado: (2020)

Presence of The NLRP3 Inflammasome Components in Semen of Varicocele Patients
por: Baazm, Maryam, et al.
Publicado: (2020)

Correction: Residue-based propensity of aggregation in the Tau amyloidogenic hexapeptides AcPHF6* and AcPHF6
por: Dangi, Abha, et al.
Publicado: (2022)

Lipocalin-2 Deficiency Diminishes Canonical NLRP3 Inflammasome Formation and IL-1β Production in the Subacute Phase of Spinal Cord Injury
por: Müller, Nina, et al.
Publicado: (2023)

Comparison of infarct volume and behavioral deficit in Wistar Kyoto and spontaneously hypertensive rat after transient occlusion of the middle cerebral artery
por: Garcia, Jorge, et al.
Publicado: (2013)

Erythropoietin Abrogates Post-Ischemic Activation of the NLRP3, NLRC4, and AIM2 Inflammasomes in Microglia/Macrophages in a TAK1-Dependent Manner
por: Heinisch, Ole, et al.
Publicado: (2021)

Capping Amyloid β-Sheets of the Tau-Amyloid Structure VQIVYK with Hexapeptides Designed To Arrest Growth. An ONIOM and Density Functional Theory Study
por: Plumley, Joshua A., et al.
Publicado: (2014)

Hypochlorous Acid-Activated UCNPs-LMB/VQIVYK Multifunctional Nanosystem for Alzheimer’s Disease Treatment
por: Qiao, Luying, et al.
Publicado: (2023)

The role of NLRP3 inflammasome for microglial response to peripheral inflammation
por: Garaschuk, Olga
Publicado: (2020)

Microglial-specific depletion of TAK1 is neuroprotective in the acute phase after ischemic stroke
por: Zeyen, Thomas, et al.
Publicado: (2020)

Aggregated Tau activates NLRP3–ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo
por: Stancu, Ilie-Cosmin, et al.
Publicado: (2019)

A Fatal Alliance between Microglia, Inflammasomes, and Central Pain
por: Hoffmann, Stefanie, et al.
Publicado: (2020)

Role of NLRP3 inflammasomes in monocyte and microglial recruitments in choroidal neovascularization
por: Dieckmann, Blake W., et al.
Publicado: (2023)

Effect of Trehalose and Ceftriaxone on the Stability of Aggregating-Prone Tau Peptide Containing PHF6* Sequence: An SRCD Study
por: Honisch, Claudia, et al.
Publicado: (2022)

PHF-Core Tau as the Potential Initiating Event for Tau Pathology in Alzheimer’s Disease
por: Luna-Viramontes, Nabil Itzi, et al.
Publicado: (2020)

Systemic inflammation impairs microglial Aβ clearance through NLRP3 inflammasome
por: Tejera, Dario, et al.
Publicado: (2019)

Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
por: Pike, Adrianne F., et al.
Publicado: (2022)

Targeting microglial autophagic degradation of the NLRP3 inflammasome for identification of thonningianin A in Alzheimer’s disease
por: Zhou, Xiao-Gang, et al.
Publicado: (2022)

Microglial exosomes alleviate intermittent hypoxia-induced cognitive deficits by suppressing NLRP3 inflammasome
por: Zhang, Yaodan, et al.
Publicado: (2023)

The NLRP3 inflammasome modulates tau pathology and neurodegeneration in a tauopathy model
por: Stancu, Ilie Cosmin, et al.
Publicado: (2022)

Phosphorylation and O-GlcNAcylation of the PHF-1 Epitope of Tau Protein Induce Local Conformational Changes of the C-Terminus and Modulate Tau Self-Assembly Into Fibrillar Aggregates
por: Cantrelle, François-Xavier, et al.
Publicado: (2021)

Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflammasome and mitophagy
por: Han, Xiaojuan, et al.
Publicado: (2021)

Amyloid‐β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk‐AMPK pathway
por: Jung, Eun Sun, et al.
Publicado: (2022)

PHLDA1 modulates microglial response and NLRP3 inflammasome signaling following experimental subarachnoid hemorrhage
por: Lai, Jinqing, et al.
Publicado: (2023)

Hyperammonemia induces microglial NLRP3 inflammasome activation via mitochondrial oxidative stress in hepatic encephalopathy
por: Cheon, So Yeong, et al.
Publicado: (2023)

Regulation of Inflammasomes by Application of Omega-3 Polyunsaturated Fatty Acids in a Spinal Cord Injury Model
por: Baazm, Maryam, et al.
Publicado: (2021)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

Administration of Dexmedetomidine inhibited NLRP3 inflammasome and microglial cell activities in hippocampus of traumatic brain injury rats
por: Zheng, Bin, et al.
Publicado: (2018)

NLRP3 inflammasome-mediated microglial pyroptosis is critically involved in the development of post-cardiac arrest brain injury
por: Chang, Yuan, et al.
Publicado: (2020)

The Anti-diabetic Drug Gliquidone Modulates Lipopolysaccharide-Mediated Microglial Neuroinflammatory Responses by Inhibiting the NLRP3 Inflammasome
por: Kim, Jieun, et al.
Publicado: (2021)

Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson’s Disease
por: Li, Yunna, et al.
Publicado: (2021)

Corrigendum: Amyloid‐β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk‐AMPK pathway
Publicado: (2022)

Aggregated Hendra virus C-protein activates the NLRP3 inflammasome to induce inflammation
por: Barry, Kristian, et al.
Publicado: (2023)

Oxidative Stress Conditions Result in Trapping of PHF-Core Tau (297–391) Intermediates
por: Maina, Mahmoud B., et al.
Publicado: (2021)

Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice
por: Feng, Jie, et al.
Publicado: (2018)

Naringenin Produces Neuroprotection Against LPS-Induced Dopamine Neurotoxicity via the Inhibition of Microglial NLRP3 Inflammasome Activation
por: Chen, Ce, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7hlllliv0q9m6h08ku0a0um9re